Endoscopic management of colonic perforation owing to angiogenesis inhibitors

Surgical Laparoscopy, Endoscopy and Percutaneous Techniques

Volumn 20, Issue 6, 2010, Pages

  Ezzedine, Salah ^a   Bege, Thierry ^a   Berdah, Stephan ^a   Vitton, Veronique ^a   Grimaud, Jean Charles ^a   Barthet, Marc ^a  

^a HÔPITAL NORD   (France)

Author keywords

bevacizumab (Avastin); colonic perforation; covered stent; digestive stenting; Metastatic colorectal cancer; self expandable metallic stent

Indexed keywords

ANTIBIOTIC AGENT; BEVACIZUMAB;

ABDOMINAL PAIN; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CASE REPORT; COLON PERFORATION; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DIET RESTRICTION; EMERGENCY CARE; ENDOSCOPIC THERAPY; HOSPITAL READMISSION; HUMAN; KIDNEY CANCER; LIVER METASTASIS; LUNG METASTASIS; MALE; PRIORITY JOURNAL; PROSTHESIS FAILURE; PSOAS ABSCESS; STENT;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; COLONIC DISEASES; ENDOSCOPY, GASTROINTESTINAL; HUMANS; INTESTINAL PERFORATION; KIDNEY NEOPLASMS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; STENTS;

EID: 78650807463     PISSN: 15304515     EISSN: 15344908     Source Type: Journal    
DOI: 10.1097/SLE.0b013e318200a115     Document Type: Article

References (17)

1. Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med. 2005;352:476-487.
2. Motl S. Bevacizumab in combination chemotherapy for colorectal and other cancers. Am J Health Syst Pharm. 2005;62:1021-1032.
3. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335-2342.
4. Han E, Monk BJ. (Editorial) What is the risk of bowel perforation associated with bevacizumab therapy in ovarian cancer? Gynecol Oncol. 2007;105:3-6.
5. Schellhaas E, Loddenkemper C, Schmittel A, et al. Bowel perforation in non-small lung cancer after bevacizumab therapy. Invest New Drugs. 2009;27:184-187.
6. Bege T, Lelong B, Viret F, et al. Bevacizumab-related surgical site complication despite primary tumor resection in colorectal cancer patients. Ann Surg Oncol. 2009;16:856-860. [Published online: 21 January 2009].
7. Giantonio BJ, Catalano PJ, Meropol NJ, et al. High-dose bevacizumab in combination with FOLFOX4 improves survival in patients with previously treated advanced colorectal cancer: results from the Eastern Cooperative Group (ECOG) study E2300. In: Proceedings of the 2005 Gastrointestinal Cancers Symposium, 2005:168. (Abstract)
8. Kabbinavar FF, Hambleton J, Mass RD, et al. Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/ leucovorin improves survival for patients with metastatic colorectal cancer. J Clin Oncol. 2005;23:3706-3712.
9. Van Cutsem E, Claus-Henning Kö hne CH, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for Metastatic Colorectal Cancer. N Engl J Med. 2009;360:1408-1417.
10. Gordon MS, Cunningham D. Managing patients treated with bevacizumab combination therapy. Oncology. 2005;69 (suppl 3):25.
11. Collins D, Ridgway PF, Winter DC, et al. Gastrointestinal perforation in metastatic carcinoma: a complication of Bevacizumab therapy. EJSO. 2009;35:444-446.
12. Giantonio BJ, Chen HX, Catalano PJ, et al. Bowel perforation and fistula formation in colorectal cancer patients treated on Eastern Cooperative Oncology Group studies E2200 and E3200 (abstract). Proc Am Soc Clin Oncol. 2004;23:199a.
13. Scappaticci FA, Fehrenbacher L, Cartwright T, et al. Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab. J Surg Oncol. 2005;91: 173-180.
14. Khot UP, Lang AW, Murali K, et al. Systematic review of the efficacy and safety of colorectal stents. Br J Surg. 2002;89: 1096-1102.
15. Amrani L, Menard C, Berdah S, et al. From iatrogenic digestive perforation to complete anastomotic disunion: endoscopic stenting as a new concept of "stent-guided regeneration and re-epithelialization". Gastrointest Endosc. 2009;69:1282-1287.
16. Farrell JJ, Preoperative colonic stenting: How, When, and Why? Curr Opin Gastroenterol. 2007;23:544-549.
17. Simmons DT, Baron TH. Technology insight: enteral stenting and new technology. Nat Clin Pract Gastroenterol Hepatol. 2005;2:365-374.